Clinical Trials

Patient-derived organoid model and circulating tumor cells for treatment response of lung cancer

Cancer Type

Lung

ClinicalTrials.gov Identifier

NCT03655015

Principal Investigator

Josephine Taverna, MD

For more information about this study
View Details

About This Study

Create a living biobank of PDOs from Stage I-III lung cancer patients.

What is the criteria to participate?

Note: This is only a partial list of eligibility criteria.

Inclusion Criteria:
Inclusion criteria
  • Read, consented to and signed the IRB-approved informed consent form prior to any study related procedure.
  • Diagnosis of lung cancer or lung mass or lymphadenopathy that will undergo tumor resection as part of standard of care
  • Any clinical stage
  • Adult patients ≥18 years of age
  • Able and willing to complete a questionnaire on their environmental/occupational exposures and smoking/alcohol history
Exclusion Criteria:
Exclusion Criteria
  • At the discretion of the treating physician, patient will not be able to fulfill the requirements of the study.